ICG
LABU icon

InterOcean Capital Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

InterOcean Capital Group’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,100
Closed -$83.8K – 488
2023
Q3 		$83.8K Buy
+1,100
New +$113K ﹤0.01% 435
2023
Q2 		– Sell
-750
Closed -$73.7K – 474
2023
Q1 		$73.7K Buy
750
+150
+25% +$20.3K ﹤0.01% 405
2022
Q4 		$84.8K Buy
+600
New +$83.7K ﹤0.01% 392

Other funds holding LABU

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

InterOcean Capital Group's LABU Position: Q4 2023 in Review

InterOcean Capital Group sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2023, closing a stake of 1,100 shares — an estimated $83.8K sold.

InterOcean Capital Group first reported a position in LABU in Q4 2022 and held it in 3 quarters. The position peaked at $84.8K in Q4 2022. 41 funds tracked by Wall St. Rank hold LABU as of Q4 2023.

  • InterOcean Capital Group reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2023 after selling out during the quarter.
  • InterOcean Capital Group sold 1,100 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2023, an estimated $83.8K.
  • InterOcean Capital Group first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2022 and held it in 3 quarters.
  • InterOcean Capital Group's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $84.8K in Q4 2022.
  • 41 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2023.

Based on InterOcean Capital Group's 13F filing for Q4 2023, filed 9 Feb 2024.